Rezolve AI heads into its September 1 earnings report with a notable shift in positioning — short sellers have retreated meaningfully over the past week, yet the borrow market and options desk remain far from relaxed.
The short-covering story is the most concrete change since the August 25 spike. Short interest has fallen to 10.7% of the free float — roughly 32.3 million shares — down from 35.9 million a week ago, a decline of about 7% on the week and 15% over the past month. That unwinding follows a period when bears were actively rebuilding into the rally, a dynamic flagged in earlier coverage. The retreat is real, but the structural overhang has not cleared: 10.7% short interest on a small-cap AI stock is still a heavy position. Cost to borrow has eased considerably — from a peak of 158% annualised in early August to 14.1% now — but that normalisation came alongside a meaningful loosening in borrow availability, which has risen to roughly 51%. That's still tight by historical standards. The 52-week low was near zero, and availability has only recently climbed back through the 50% threshold after weeks pinned in the 20–30% range. The ORTEX short score of 74.2 reflects the continued pressure — still deeply elevated, even if it has edged off last week's peak above 78.
Options traders are not leaning defensively into the print at all. The put/call ratio of 0.28 is virtually in line with its 20-day average and sits well below its 52-week high of 0.33. That call-side tilt has been persistent throughout August, even as short sellers were building and rebuilding positions — suggesting equity options participants are positioned for continued upside while the short book hedges against it. The contrast between those two signals has been a defining feature of this setup all month, and it has not resolved.
The ownership picture adds texture worth noting. Alejandro Gonzalez, listed among the top holders, added 7.25 million shares as recently as mid-July — a meaningful addition that brings his stake to 7.5% of shares. That move stands apart from the insider buying by Founder and Chairman/CEO Daniel Wagner in early April, which totalled over $3.2 million across two transactions at $4.00 per share. With the stock now trading near $2.97, those April purchases are underwater, which frames the September 1 print as a meaningful test of the bull case on management's own terms.
On the fundamental debate, the tension is stark. ORTEX notes describe bulls projecting 2026 revenue near $350 million — roughly double street consensus — on the back of an AI commerce platform that reached profitability in 2025 and is aggressively building partnerships. Bears counter with concerns about dilution risk, execution uncertainty, and quality metrics that remain deeply negative: return on assets is severely impaired and the Piotroski F-score signals fragile financial health. Peers have largely outrun RZLV this year, with correlated names like MTLS up 14% on the week and CRWD surging nearly 20% in a single session Friday — moves that highlight the momentum the AI software cohort has generated without RZLV participating proportionally.
The September 1 print is therefore a test of whether the company's own growth narrative can outrun a borrow market that has structurally tightened all year, a short book that trimmed but has not capitulated, and a stock that has rallied 29% in a month without yet recovering to the levels where its own CEO bought.
See the live data behind this article on ORTEX.
Open RZLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
